METHOD FOR TREATING A DISEASE CHARACTERIZED BY INCREASED APPETITE
- 专利权人:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 发明人:
- JOHANNES GROSSE,HELEN HEFFRON,KATE DAY
- 申请号：
- US13949914
- 公开号：
- US20140161795A1
- 申请日:
- 2013.07.24
- 申请国别(地区):
- US
- 年份:
- 2014
- 代理人:
- 摘要：
- Insl5 has been found to be orexigenic, i.e. it increases appetite. Insl5, or a derivative or fragment thereof that retains the ability to bind to the GPR100 receptor, or an Insl5 antibody, are useful in therapy, in particular to treat anorexia nervosa, bulimia, cachexia or wasting disease.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Appetite control compounds
- Method for treating a disease characterized by reduced appetite
- Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
- Cachexia and / or anorexia and / or anorexia-ghrelin splice mutation to treat cachexia and / or malnutrition and / or lipodystrophy and / or muscle wasting and / or appetite-stimulation Use of the body
- USE OF GHRELIN SPLICE VARIANT FOR TREATING CACHEXIA AND/OR ANOREXIA AND/OR ANOREXIA-CACHEXIA AND/OR MALNUTRITION AND/OR LIPODYSTROPHY AND/OR MUSCLE WASTING AND/OR APPETITE STIMULATION
